|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0752 SEK | -5.41% |
|
-13.96% | -78.70% |
| Apr. 05 | Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic | CI |
| Apr. 05 | Diagonal Bio AB Announces Successful Pilot Study Results | CI |
Diagonal Bio AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 8.67 million. Revenue was SEK 8.72 million.
Net loss was SEK 11.12 million. Basic loss per share from continuing operations was SEK 1.62.
| 1st Jan change | Capi. | |
|---|---|---|
| -78.70% | 2.75M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
DIAGONAL BIO AB 
